Generative AI-Powered Intrapartum Clinical Decision Support Among Healthcare Providers
Generative AI-Powered Intrapartum Clinical Decision Support and Healthcare Providers' Decision-Making Speed, Diagnostic Accuracy, Satisfaction, and Clinical Experience: A Quasi-Experimental Study
Pregnancy and childbirth are uniquely important events in women's lives because they are accompanied by major physical, emotional, and psychological changes. Maternal satisfaction, emotional well-being, and perceptions of childbirth are strongly influenced by the quality of labor management. A woman's childbirth experience is shaped by multiple factors, including communication, autonomy, and active participation in the decision-making process. These factors are widely recognized as important indicators of the quality of maternity care. [1]
Recent demographic changes and global population growth have placed increasing demands on healthcare systems, particularly maternal health services. High birth rates in some regions, combined with shortages of trained healthcare professionals, have created a need for scalable, adaptable, and innovative models of care. In response to these challenges, digital health technologies have emerged as promising tools to enhance the quality of maternity care and support both healthcare providers and pregnant women. [2]
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
This single-center, non-randomized, parallel-group quasi-experimental study evaluated a generative AI-powered intrapartum clinical decision-support chatbot among healthcare providers involved in normal labor management.
The study included 427 obstetricians and nurses: 214 in the intervention group and 213 in the control group. Providers in the intervention group used the AI-based Smart Normal Labor application to support clinical assessment and decision-making during routine labor care. Providers in the control group followed conventional institutional care practices without using the application.
The evaluation combined assessments of clinical decision-making performance with provider-reported satisfaction, acceptance, clinical experience, and workflow. It also explored perceived barriers and facilitators to application use in clinical practice. The study focused on provider-level outcomes; maternal and neonatal clinical outcomes were not directly assessed.
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Dakahlia Governorate
-
Al Mansurah, Dakahlia Governorate, Ägypten, 35712
- Basma wageah Basma
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria
Obstetricians and nurses working in the Labor Kiosk, Obstetrics and Gynecology Department, or Outpatient Gynecology Clinics at Mansoura University Hospital.
Direct involvement in the care and supervision of women in active labor.
At least six months of clinical experience in labor management. For the intervention group: completion of at least two months of training on the generative AI-powered Smart Normal Labor intrapartum chatbot before its use with clinical cases during the intervention.
For the intervention group: use of the generative AI-powered Smart Normal Labor intrapartum chatbot during clinical labor management.
For the control group: provision of routine care without prior use of the study chatbot.
Willingness to participate and provide informed consent.
Exclusion Criteria
Healthcare providers not directly involved in labor management, including administrative staff and laboratory personnel.
Less than six months of clinical experience in labor management.
Being on leave or unavailable during the study period.
Declining participation or not providing informed consent.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Generative AI-Powered Intrapartum Chatbot Decision Support Group
Healthcare providers used the generative AI-powered Smart Normal Labor intrapartum chatbot to support clinical assessment, interpretation of labor progress, and clinical decision-making during normal labor management. The chatbot was used alongside routine institutional care practices. |
Smart Normal Labor is a mobile application incorporating a generative AI-powered chatbot for healthcare providers. It provides interactive clinical decision support using information entered by providers about labor progress and clinical findings. Its intended functions include supporting interpretation of clinical information and formulation of a management plan.
Andere Namen:
|
|
Kein Eingriff: Routine Care Group
Healthcare providers managed normal labor according to routine institutional care practices without using the generative AI-powered intrapartum chatbot. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Time to a Confirmed Intrapartum Management Decision
Zeitfenster: During the assessed intrapartum clinical encounter, from case presentation to confirmation of the management decision ,5 months
|
Elapsed time, measured in minutes, from admission of the woman in labor to confirmation of a clinical management plan by the healthcare provider. Shorter times indicate faster clinical decision-making. |
During the assessed intrapartum clinical encounter, from case presentation to confirmation of the management decision ,5 months
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Diagnostic Accuracy in Intrapartum Clinical Cases
Zeitfenster: During the assessed intrapartum clinical encounter, at completion of the diagnostic assessment ,5 months.
|
Percentage of assessed intrapartum clinical cases in which the healthcare provider's diagnosis agrees with the study-defined reference diagnosis, compared between the AI-supported intervention group and the conventional-care control group. Higher percentages indicate greater diagnostic accuracy. |
During the assessed intrapartum clinical encounter, at completion of the diagnostic assessment ,5 months.
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- Smart Normal Labor
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .